Prosecution Insights
Last updated: May 29, 2026
Application No. 18/272,493

METHOD FOR CONTROLLING WEEDS

Non-Final OA §103
Filed
Jul 14, 2023
Priority
Jan 19, 2021 — JP 2021-006180 +1 more
Examiner
KIFLE, BRUCK
Art Unit
1624
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Kumiai Chemical Industry Co. Ltd.
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
1360 granted / 1718 resolved
+19.2% vs TC avg
Strong +16% interview lift
Without
With
+15.9%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
30 currently pending
Career history
1745
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
16.9%
-23.1% vs TC avg
§102
10.0%
-30.0% vs TC avg
§112
50.9%
+10.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1718 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-6 are rejected under 35 U.S.C. 103 as being unpatentable over Uchida et al. (WO 2021/002484, which corresponds to US 2023/0012374). The reference teaches crystals pyroxasulfone for use as an herbicide (see Example 3, page 86). The claimed method in claim 1 differs by requiring the soil to be treated to have “a clay content of less than 15% and a sand content of not less than 65%” and claim 2 differs by requiring in addition to the soli limitation to have an agrochemical formulation obtained through a step of pulverizing a powder or slurry containing crystals of pyroxasulfone. The reference is silent on the nature of soil and does not measure the amount of clay and/or sand of the soil being treated. However, one skilled in the art would be motivated to use crystals of pyroxasulfone to control weeds in any type of soil, including soil that has clay content of less than 15% and a sand content of not less than 65% as instantly specified in the claims, because the reference teaches the usefulness of crystals of pyroxasulfone as an herbicide with the expectation of achieving similar results. Requiring pulverized or a slurry in an agrochemical formulation is routine in the art to disperse agrochemicals. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRUCK KIFLE whose telephone number is (571)272-0668. The examiner can normally be reached 8 AM - 6 PM, M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jeffrey H. Murray can be reached at 571-272-9023. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. March 10, 2026 /BRUCK KIFLE/Primary Examiner, Art Unit 1624
Read full office action

Prosecution Timeline

Jul 14, 2023
Application Filed
Mar 12, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12624026
INHIBITORS OF SARM1
5y 5m to grant Granted May 12, 2026
Patent 12623994
METHOD OF PREPARING HETEROGENEOUS LINEAR CARBONATE USING CATALYST HAVING EXCELLENT SOLUBILITY
2y 11m to grant Granted May 12, 2026
Patent 12617761
PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE
2y 10m to grant Granted May 05, 2026
Patent 12612371
SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF
3y 10m to grant Granted Apr 28, 2026
Patent 12604894
SOLID PESTICIDAL FORMULATION
2y 11m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
95%
With Interview (+15.9%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1718 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month